Driving under the influence (DUI) of psychoactive substances is an issue of paramount concern in both public health and the criminal justice system. It affects millions of Americans yearly, and while there is extensive research on DUI among...
During their day-to-day work, first responders such as law enforcement officers, firefighters, and emergency medical services (EMS) personnel often encounter people who use drugs (PWUD), including alcohol, opioids, stimulants, and...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Lo scopo di questa guida alle risorse è condividere una panoramica di ROSC e illustrare come questi sistemi siano parte integrante del nuovo ambiente sanitario. Questa guida allineerà i principi della riforma sanitaria ai benefici, al...
Ogni settembre la campagna Recovery Month mira ad aumentare la consapevolezza e la comprensione dei disturbi mentali e dell'uso di sostanze e celebrare le persone che guariscono.
Nel corso degli anni, il Recovery Month ha promosso e...
The Substance Abuse and Mental Health Services Administration (SAMHSA) National Center of Excellence for Tobacco-Free Recovery Grant is now open for applications. Offering up to 5 million USD the grant can be used for a range of projects...
